FOLH1 and nonpapillary renal cell carcinoma: As PSMA has been previously identified in neovasculature of clear cell RCC (ccRCC), <sup>68</sup>Ga-PSMA-Positron Emitted Tomography (PET) could appear as an interesting tool to evaluate therapeutic response.